Michel Sadelain

Columbia University Irving Medical Center

Also affiliated with Columbia University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Senolytic CAR T cells reverse senescence-associated pathologies”.

Senolytic CAR T cells reverse senescence-associated pathologies

Nature(2020)10.1038/s41586-020-2403-9

N/A

7.8DataRank · unranked

1061 citations

Judith Feucht, Josef Leibold, Yu-Jui Ho, Changyu Zhu, Direna Alonso‐Curbelo +13 more

GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy

Molecular Therapy(2024)10.1016/j.ymthe.2024.05.006

N/A

1.4DataRank · unranked

74 citations

Ivan S. Kotchetkov, Anton Dobrin, Sophie Hanina, Vinagolu K. Rajasekhar, John H. Healey +2 more

824 High quality neoantigens are immunoedited in long-term pancreatic cancer survivors

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.824

N/A

0DataRank · unranked

0 citations

Marta Łuksza, Luis A. Rojas, Kevin C. Soares, Joanne Leung, Jayon Lihm +18 more

Neoantigen quality predicts immunoediting in survivors of pancreatic cancer

Nature(2022)10.1038/s41586-022-04735-9

N/A

0DataRank · unranked

203 citations

Zachary Sethna, Luis A. Rojas, Jayon Lihm, Barbara Bravi, Yuval Elhanati +28 more

HLA-independent T cell receptors for targeting tumors with low antigen density

Nature Medicine(2022)10.1038/s41591-021-01621-1

N/A

0DataRank · unranked

185 citations

Justin Eyquem, Sascha Haubner, Mohamad Hamieh, Judith Feucht, Noémie Paillon +20 more

CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004128

N/A

0DataRank · unranked

36 citations

David Qualls, Sébastien Monette, Shenon Sethi, Ahmet Doǧan, Mikhail Roshal +8 more

Globin vector regulatory elements are active in early hematopoietic progenitor cells

Molecular Therapy(2022)10.1016/j.ymthe.2022.02.028

N/A

0DataRank · unranked

9 citations

Ashlesha Odak, Lee Zamparo, Han Yuan, Christina S. Leslie, Michel Sadelain +1 more

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

Nature(2023)10.1038/s41586-023-06063-y

N/A

0DataRank · unranked

1289 citations

Zachary Sethna, Kevin C. Soares, Cristina Olcese, Nan Pang, Erin Patterson +46 more

CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

Nature Medicine(2023)10.1038/s41591-023-02404-6

N/A

0DataRank · unranked

167 citations

Karthik Nath, Sean M. Devlin, Craig S. Sauter, M. Lia Palomba, Gunjan L. Shah +14 more

Cooperative CAR targeting to selectively eliminate AML and minimize escape

Cancer Cell(2023)10.1016/j.ccell.2023.09.010

N/A

0DataRank · unranked

113 citations

Jorge Mansilla‐Soto, Sarah Nataraj, Friederike Kogel, Qing Chang, Elisa de Stanchina +9 more

CD19 CAR antigen engagement mechanisms and affinity tuning

Science Immunology(2023)10.1126/sciimmunol.adf1426

N/A

0DataRank · unranked

76 citations

Jorge Mansilla‐Soto, Nandish Khanra, Mohamad Hamieh, Victor Bustos, Alice J. Paquette +7 more

Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology

Journal of Molecular Diagnostics(2023)10.1016/j.jmoldx.2023.06.002

N/A

0DataRank · unranked

3 citations

Utsav Patel, Amir Momeni Boroujeni, JinJuan Yao, Roger Chan, Joe Chan +18 more

Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction

Nature Aging(2024)10.1038/s43587-023-00560-5

N/A

0DataRank · unranked

190 citations

Inés Fernández-Maestre, Saria Chowdhury, Yu-Jui Ho, Sandeep Nadella, Courtenay Graham +14 more

Senolytic CAR T cells reverse aging-associated defects in intestinal regeneration and fitness

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.19.585779

N/A

0DataRank · unranked

10 citations

Saria Chowdhury, Vyom Shah, Emmanuella Nnuji-John, Charlie Chung, Jacob A. Boyer +6 more

CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.26.582108

N/A

0DataRank · unranked

11 citations

Tal Cohen, Natalie Zimmerman, Friederike Dündar, Paul Zumbo, Razan Eltilib +14 more

Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma

Research Square(2024)10.21203/rs.3.rs-4619285/v1

N/A

0DataRank · unranked

2 citations

M. Lia Palomba, Karlo Perica, Sean M. Devlin, Gunjan L. Shah, Parastoo B. Dahi +28 more

CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53

New England Journal of Medicine(2025)10.1056/nejmoa2411507

N/A

0DataRank · unranked

86 citations

Nayan Jain, Michael Scordo, Ruchi Patel, Özgür Can Eren, Utsav Patel +21 more

CAR-engineered lymphocyte persistence is governed by a FAS ligand–FAS autoregulatory circuit

Nature Cancer(2025)10.1038/s43018-025-01009-x

N/A

0DataRank · unranked

30 citations

Tal Cohen, Natalie Zimmerman, Friederike Dündar, Paul Zumbo, Razan Eltilib +18 more

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0407

N/A

0DataRank · unranked

570 citations

Marjorie G. Zauderer, Isabelle Rivière, Stephen B. Solomon, Valerie W. Rusch, Roisin E. O’Cearbhaill +25 more